Argus Backs SpaceX After AI Spending Spooks Its First Report
SpaceX's debut earnings report put its artificial intelligence spending under a harsh light and the stock fell. Argus Research then took the other side of that trade, and the tape has since moved sharply…
Argus Research issued a supportive view on Space Exploration Technologies Corp (NASDAQ: SPCX) two days after investors sold the stock over artificial intelligence spending disclosed in its first earnings report as a public company; SPCX last closed at $133.11, up 15.83% on the day.
The first earnings report a company files as a public entity is rarely judged on the whole. Investors pick one line, decide what it means, and trade it. For Space Exploration Technologies Corp (NASDAQ: SPCX), that line was artificial intelligence spending — and the initial verdict was negative enough to send the shares lower.
Two days later, Argus Research took the other side. As TheStreet reported, the research firm's read on the same disclosures ran directly against the market's reaction, treating the AI outlay as something other than a reason to sell.
What the market decided to punish
The mechanics of the sell-off are familiar to anyone who has watched the AI capital expenditure debate play out across large-cap technology this cycle. A company reports. Spending on compute, data centers, models or engineering headcount comes in heavier than the sell side had penciled in. Free cash flow guidance tightens as a result. The stock trades down, sometimes hard, before anyone has had time to argue about whether the spending is productive.
SpaceX walked into that pattern with the added disadvantage of having no track record as a listed reporter. There was no prior quarter for investors to anchor on, no established pattern of management under-promising and over-delivering, and no history of AI investment converting into revenue on a schedule shareholders had learned to trust. In that vacuum, a single spending figure carries far more weight than it would at a company with years of filings behind it.
Newly public companies also carry a distinct shareholder mix. Allocations from the offering sit in hands that have not committed to a multi-year thesis, and the first report is the first genuine opportunity to reprice. Selling into a debut disappointment is often a positioning event as much as a fundamental one.
Where the shares actually stand
Whatever the market thought immediately after the report, the most recent tape does not look like capitulation. SPCX last closed at $133.11, a gain of 15.83% on the day, against a previous close of $114.92 — a move of roughly $18 per share in a single session. The stock traded between $114.53 and $133.48 during that day, meaning it finished within a whisker of its high and effectively at the top of its range.
Context matters here. The broad market was firm but not remotely that strong on the same day. The S&P 500, via SPY, closed at $773.26, up 0.61%. The Nasdaq 100 tracker QQQ closed at $723.03, up 1.17%. The Dow 30 proxy DIA closed at $539.62, up 0.27%. A double-digit percentage move in a single name on a day when the technology-heavy benchmark advanced barely more than one percent is stock-specific news, not beta.
All of those figures are as of the last trade on Friday, 7 August 2026. Markets are closed, so these are closing marks rather than live quotes.
Why a research house can look at the same number and shrug
The analytical split on AI spending comes down to one question: is the outlay an expense or an asset? Treated as an expense, heavy AI investment is pure margin compression — money out the door against uncertain return, and a reason to mark down near-term cash flow estimates. Treated as an asset, it is capital being deployed into capability the company will monetize later, and cutting it would be the actual bear case.
The analytical split on AI spending comes down to one question: is the outlay an expense or an asset?
Research firms that lean toward the second interpretation typically look for a few things. They want the spending tied to identifiable workloads rather than described in the abstract. They want a sense of whether the investment is defensive — matching rivals to avoid falling behind — or offensive, opening a line of business that did not previously exist. And they want to know whether the balance sheet can absorb the program without a financing event that dilutes existing holders.
Argus's stance, running counter to the post-earnings selling, places it in the camp that reads the number as investment rather than leakage. Investors weighing that view should look for the specifics of the firm's published rating and valuation work directly, since a contrarian call is only as good as the estimates underneath it.
The AI capex argument has become the market's main fault line
This is not an isolated skirmish. Across the market this cycle, the same disclosure has produced violently different reactions depending on the credibility of the company making it. Established platforms with long records of converting capital spending into revenue have generally been given the benefit of the doubt, at least until cash flow visibly deteriorated. Companies without that history have been marked down first and questioned later.
SpaceX now sits squarely in the second group, and its first report has already established the metric that the market will use to grade it. Every subsequent quarter will be read against the AI spending line: whether it accelerates, whether management frames it as a defined program with an end point, and whether anything resembling a return begins to show up in reported results.
What to watch from here
Three things will decide whether the Argus view or the initial market reaction ages better.
- Follow-through on the tape. A 15.83% session that closes near the high of the day is a strong signal, but the durability of that move over subsequent sessions is what separates a short squeeze from a genuine repricing.
- Whether other research houses converge. A single contrarian note moves a stock; a cluster of them changes the consensus estimate base that everyone trades against.
- How management frames the spending next time. Vague commitments invite the same reaction. A program with a stated size, duration and target changes the conversation from risk to plan.
For now, the stock has recovered a great deal of ground quickly, and the disagreement between the initial sellers and at least one research firm remains unresolved on the fundamentals. The next earnings report, not the last one, will settle it.
Key facts
- SPCX last close: $133.11, +15.83% (as of Fri, 07 Aug 2026, 20:00 GMT)
- Previous close / day range: $114.92; traded $114.53–$133.48
- Analyst action: Argus Research took a view counter to the post-earnings selling
- Trigger: SpaceX's first earnings report as a public company; AI spending in focus
Frequently asked questions
Why did SpaceX stock fall after its first earnings report?
According to the lead reporting, the market fixated on how much SpaceX is spending on artificial intelligence in its debut report as a public company. Heavy AI outlays typically compress near-term margins and free cash flow estimates, and investors sold the shares in response. The specific spending figure was the focus of the reaction rather than the report as a whole.
What did Argus Research say about SPCX?
Argus Research commented on SpaceX two days after the heavy investor selling, and its view ran counter to the market's negative reaction to the AI spending disclosure. The firm's specific rating and valuation work should be reviewed directly through its published research, as the details of the target were not part of the reporting summarized here.
Where does SPCX stock currently trade?
Markets are closed. Space Exploration Technologies Corp last closed at $133.11, a gain of 15.83% on the day from a previous close of $114.92. The shares traded between $114.53 and $133.48 in that session, finishing near the top of the range. Those marks are as of Friday, 7 August 2026 at 20:00 GMT.
How did the broader market perform on the same day?
The S&P 500 tracker SPY closed at $773.26, up 0.61%. The Nasdaq 100 proxy QQQ closed at $723.03, up 1.17%. The Dow 30 tracker DIA closed at $539.62, up 0.27%. All three were higher but nowhere near SPCX's double-digit gain, indicating the move was company-specific rather than market-driven.
Why does AI spending divide analysts so sharply?
The disagreement is whether heavy AI outlay is an expense or an investment. Read as an expense, it is margin compression against uncertain returns. Read as an investment, it is capital building future capability, and cutting it would be the real risk. Companies with long records of converting capital spending into revenue usually get more benefit of the doubt.
What should investors watch next in this story?
Three things: whether the sharp share-price recovery holds over subsequent sessions rather than fading, whether additional research houses converge on the more constructive view and lift consensus estimates, and how management frames its AI spending at the next earnings report — a defined program with stated size and duration reads very differently from an open-ended commitment.
Sources
Photo: Lando Dong · Pexels Licence — source
